Pyrimethamine labels and packages

Revision as of 21:48, 9 January 2014 by Chetan Lokhande (talk | contribs)
Jump to navigation Jump to search
Pyrimethamine
DARAPRIM® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

PRINCIPAL DISPLAY PANEL – NDC 52054-330-10[1]

[[File:|800px|thumb]]



References

  1. "DARAPRIM (PYRIMETHAMINE) TABLET [AMEDRA PHARMACEUTICALS LLC]".

Adapted from the FDA Package Insert.